| Stage | ABM | % of rev | MLKN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.3B | 100.00% | $923M | 100.00% | ABM ×2.51 |
| Gross profit | $286M | 12.35% | $385M | 41.73% | MLKN +29.4pp |
| Operating income | $92M | 3.95% | $52M | 5.61% | MLKN +1.7pp |
| Pre-tax income | $63M | 2.73% | $35M | 3.81% | MLKN +1.1pp |
| Net income | $50M | 2.14% | $28M | 2.99% | MLKN +0.8pp |
| Stage | ABM | MLKN | Gap · A − B |
|---|---|---|---|
| Revenue | $2.3B100.00% | $923M100.00% | ABM ×2.51 |
| Gross profit | 12.35%$286M | 41.73%$385M | MLKN +29.4pp |
| Operating income | 3.95%$92M | 5.61%$52M | MLKN +1.7pp |
| Pre-tax income | 2.73%$63M | 3.81%$35M | MLKN +1.1pp |
| Net income |
| 2.14%$50M |
| 2.99%$28M |
| MLKN +0.8pp |
No shared counterparties.